Found: 85
Select item for more details and to access through your institution.
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06659-8
- By:
- Publication type:
- Article
IgG1 glycosylation highlights premature aging in Down syndrome.
- Published in:
- Aging Cell, 2024, v. 23, n. 7, p. 1, doi. 10.1111/acel.14167
- By:
- Publication type:
- Article
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1288597
- By:
- Publication type:
- Article
Generation of human antibodies targeting human platelet antigen (HPA)‐1a.
- Published in:
- Transfusion, 2024, v. 64, n. 5, p. 893, doi. 10.1111/trf.17758
- By:
- Publication type:
- Article
Formation and clearance of TNF–TNF inhibitor complexes during TNF inhibitor treatment.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 8, p. 1165, doi. 10.1111/bph.16269
- By:
- Publication type:
- Article
Assessment of IgG‐Fc glycosylation from individual RhD‐specific B cell clones reveals regulation at clonal rather than clonotypic level.
- Published in:
- Immunology, 2024, v. 171, n. 3, p. 428, doi. 10.1111/imm.13737
- By:
- Publication type:
- Article
Impact of structural modifications of IgG antibodies on effector functions.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1304365
- By:
- Publication type:
- Article
N-linked Fc glycosylation is not required for IgG-B-cell receptor function in a GC-derived B-cell line.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44468-5
- By:
- Publication type:
- Article
Cellular surface plasmon resonance-based detection of anti-HPA-1a antibody glycosylation in fetal and neonatal alloimmune thrombocytopenia.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1225603
- By:
- Publication type:
- Article
Factors affecting IgG4-mediated complement activation.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2023.1087532
- By:
- Publication type:
- Article
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation.
- Published in:
- Clinical & Translational Immunology, 2023, v. 12, n. 1, p. 1, doi. 10.1002/cti2.1436
- By:
- Publication type:
- Article
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement.
- Published in:
- Nature Communications, 2022, v. 13, p. 1, doi. 10.1038/s41467-022-33764-1
- By:
- Publication type:
- Article
Role of N-Glycosylation in FcγRIIIa interaction with IgG.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.987151
- By:
- Publication type:
- Article
Affinity capillary electrophoresis - mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2022.980291
- By:
- Publication type:
- Article
Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 4, p. 673, doi. 10.1093/infdis/jiac235
- By:
- Publication type:
- Article
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.892534
- By:
- Publication type:
- Article
Antibody glycosylation in COVID-19.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 3, p. 335, doi. 10.1007/s10719-022-10044-0
- By:
- Publication type:
- Article
FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.863095
- By:
- Publication type:
- Article
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.893648
- By:
- Publication type:
- Article
Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains.
- Published in:
- European Journal of Immunology, 2022, v. 52, n. 4, p. 609, doi. 10.1002/eji.202149653
- By:
- Publication type:
- Article
Human IgE does not bind to human FcRn.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-03852-1
- By:
- Publication type:
- Article
A functional spleen contributes to afucosylated IgG in humans.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03196-w
- By:
- Publication type:
- Article
Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.754710
- By:
- Publication type:
- Article
Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26118-w
- By:
- Publication type:
- Article
Potential Diagnostic Approaches for Prediction of Therapeutic Responses in Immune Thrombocytopenia.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3403, doi. 10.3390/jcm10153403
- By:
- Publication type:
- Article
Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6763, doi. 10.3390/ijms22136763
- By:
- Publication type:
- Article
Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2372, doi. 10.3390/cancers13102372
- By:
- Publication type:
- Article
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 5, p. 1, doi. 10.1002/cti2.1285
- By:
- Publication type:
- Article
Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity.
- Published in:
- Nutrients, 2021, v. 13, n. 5, p. 1645, doi. 10.3390/nu13051645
- By:
- Publication type:
- Article
C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors in vitro.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.594773
- By:
- Publication type:
- Article
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 12, p. 1998, doi. 10.1002/eji.202048908
- By:
- Publication type:
- Article
MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N -Glycosylation.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.02049
- By:
- Publication type:
- Article
Author Correction: Human DC-SIGN and CD23 do not interact with human IgG.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01516
- By:
- Publication type:
- Article
Editorial: Roles of Fc Receptors in Disease and Therapy.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
FcγR Binding and ADCC Activity of Human IgG Allotypes.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00740
- By:
- Publication type:
- Article
Anti‐platelet antibody immunoassays in childhood immune thrombocytopenia: a systematic review.
- Published in:
- Vox Sanguinis, 2020, v. 115, n. 4, p. 323, doi. 10.1111/vox.12894
- By:
- Publication type:
- Article
Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 2, p. 1, doi. 10.1002/cti2.1112
- By:
- Publication type:
- Article
Human DC-SIGN and CD23 do not interact with human IgG.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46484-2
- By:
- Publication type:
- Article
The Ligands for Human IgG and Their Effector Functions.
- Published in:
- Antibodies (2073-4468), 2019, v. 8, n. 2, p. 30, doi. 10.3390/antib8020030
- By:
- Publication type:
- Article
Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-40731-2
- By:
- Publication type:
- Article
Development of a recombinant anti-Vel immunoglobulin M to identify Vel-negative donors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multiplex blood group typing by cellular surface plasmon resonance imaging.
- Published in:
- 2019
- By:
- Publication type:
- journal article
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2018.03124
- By:
- Publication type:
- Article
FcγR interaction is not required for effective anti‐PD‐L1 immunotherapy but can add additional benefit depending on the tumor model.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 2, p. 345, doi. 10.1002/ijc.31899
- By:
- Publication type:
- Article
A variant RhAG protein encoded by the RHAG*572A allele causes serological weak D expression while maintaining normal RhCE phenotypes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A variant RhAG protein encoded by the RHAG*572A allele causes serological weak D expression while maintaining normal RhCE phenotypes.
- Published in:
- Transfusion, 2019, v. 59, n. 1, p. 405, doi. 10.1111/trf.14969
- By:
- Publication type:
- Article
An unusual presentation of a patient with severe hypogammaglobulinemia.
- Published in:
- Clinical Case Reports, 2018, v. 6, n. 12, p. 2416, doi. 10.1002/ccr3.1877
- By:
- Publication type:
- Article
IgG Glyco-Engineering to Improve IVIg Potency.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.02442
- By:
- Publication type:
- Article